APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Plasma Fractionation

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Blood Plasma Fractionation Market Analysis and Forecast 2026-2032

20 December 2025209 pages

Choose your research edition.

Industry ResearchBlood Plasma Fractionation Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Plasma Fractionation Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Blood Plasma Fractionation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Plasma Fractionation Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Plasma Fractionation Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Blood Plasma Fractionation market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Blood Plasma Fractionation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Blood Plasma Fractionation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Blood Plasma Fractionation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Blood Plasma Fractionation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Blood Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Blood Plasma Fractionation, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Blood Plasma Fractionation, also provides the sales of main regions and countries. Of the upcoming market potential for Blood Plasma Fractionation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blood Plasma Fractionation sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Blood Plasma Fractionation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Blood Plasma Fractionation sales, projected growth trends, production technology, application and end-user industry.

Blood Plasma Fractionation Segment by Company

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Tiantan Bio

Shuanglin Bio

Boya Bio

Yuanda Shuyang

Weiguang Bio

Nanyue Bio

KM Biologics

Blood Plasma Fractionation Segment by Type

Immune Globulin

Coagulation Factor

Albumin

Others

Blood Plasma Fractionation Segment by Application

Hospital

Retail Pharmacy

Others

Blood Plasma Fractionation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Plasma Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma Fractionation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Blood Plasma Fractionation in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Blood Plasma Fractionation manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Plasma Fractionation sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Blood Plasma Fractionation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immune Globulin Major Manufacturers Table 3. Coagulation Factor Major Manufacturers Table 4. Albumin Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Blood Plasma Fractionation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Retail Pharmacy Major Manufacturers Table 9. Others Major Manufacturers Table 10. Blood Plasma Fractionation Industry Trends Table 11. Blood Plasma Fractionation Industry Drivers Table 12. Blood Plasma Fractionation Industry Opportunities and Challenges Table 13. Blood Plasma Fractionation Industry Restraints Table 14. Global Blood Plasma Fractionation Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Blood Plasma Fractionation Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Blood Plasma Fractionation Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Blood Plasma Fractionation Revenue Market Share by Region (2021-2026) Table 18. Global Blood Plasma Fractionation Revenue Market Share by Region (2027-2032) Table 19. Global Blood Plasma Fractionation Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Blood Plasma Fractionation Sales by Region (2021-2026) & (K Units) Table 21. Global Blood Plasma Fractionation Sales by Region (2027-2032) & (K Units) Table 22. Global Blood Plasma Fractionation Sales Market Share by Region (2021-2026) Table 23. Global Blood Plasma Fractionation Sales Market Share by Region (2027-2032) Table 24. Global Blood Plasma Fractionation Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Blood Plasma Fractionation Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Blood Plasma Fractionation Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Blood Plasma Fractionation Sales Market Share by Manufacturers (2021-2026) Table 28. Global Blood Plasma Fractionation Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Blood Plasma Fractionation Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Blood Plasma Fractionation Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Blood Plasma Fractionation Manufacturers, Product Type & Application Table 32. Global Blood Plasma Fractionation Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Blood Plasma Fractionation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Blood Plasma Fractionation Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Blood Plasma Fractionation Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Blood Plasma Fractionation Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Blood Plasma Fractionation Revenue Market Share by Type (2021-2026) Table 39. Global Blood Plasma Fractionation Revenue Market Share by Type (2027-2032) Table 40. Global Blood Plasma Fractionation Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Blood Plasma Fractionation Sales by Type (2021-2026) & (K Units) Table 42. Global Blood Plasma Fractionation Sales by Type (2027-2032) & (K Units) Table 43. Global Blood Plasma Fractionation Sales Market Share by Type (2021-2026) Table 44. Global Blood Plasma Fractionation Sales Market Share by Type (2027-2032) Table 45. Global Blood Plasma Fractionation Price by Type (2021-2026) & (US$/Unit) Table 46. Global Blood Plasma Fractionation Price by Type (2027-2032) & (US$/Unit) Table 47. Global Blood Plasma Fractionation Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Blood Plasma Fractionation Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Blood Plasma Fractionation Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Blood Plasma Fractionation Revenue Market Share by Application (2021-2026) Table 51. Global Blood Plasma Fractionation Revenue Market Share by Application (2027-2032) Table 52. Global Blood Plasma Fractionation Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Blood Plasma Fractionation Sales by Application (2021-2026) & (K Units) Table 54. Global Blood Plasma Fractionation Sales by Application (2027-2032) & (K Units) Table 55. Global Blood Plasma Fractionation Sales Market Share by Application (2021-2026) Table 56. Global Blood Plasma Fractionation Sales Market Share by Application (2027-2032) Table 57. Global Blood Plasma Fractionation Price by Application (2021-2026) & (US$/Unit) Table 58. Global Blood Plasma Fractionation Price by Application (2027-2032) & (US$/Unit) Table 59. Takeda Company Information Table 60. Takeda Business Overview Table 61. Takeda Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Takeda Blood Plasma Fractionation Product Portfolio Table 63. Takeda Recent Development Table 64. CSL Company Information Table 65. CSL Business Overview Table 66. CSL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. CSL Blood Plasma Fractionation Product Portfolio Table 68. CSL Recent Development Table 69. Grifols Company Information Table 70. Grifols Business Overview Table 71. Grifols Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Grifols Blood Plasma Fractionation Product Portfolio Table 73. Grifols Recent Development Table 74. Octapharma Company Information Table 75. Octapharma Business Overview Table 76. Octapharma Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Octapharma Blood Plasma Fractionation Product Portfolio Table 78. Octapharma Recent Development Table 79. Kedrion Company Information Table 80. Kedrion Business Overview Table 81. Kedrion Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Kedrion Blood Plasma Fractionation Product Portfolio Table 83. Kedrion Recent Development Table 84. LFB Group Company Information Table 85. LFB Group Business Overview Table 86. LFB Group Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. LFB Group Blood Plasma Fractionation Product Portfolio Table 88. LFB Group Recent Development Table 89. Biotest Company Information Table 90. Biotest Business Overview Table 91. Biotest Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Biotest Blood Plasma Fractionation Product Portfolio Table 93. Biotest Recent Development Table 94. BPL Company Information Table 95. BPL Business Overview Table 96. BPL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. BPL Blood Plasma Fractionation Product Portfolio Table 98. BPL Recent Development Table 99. RAAS Company Information Table 100. RAAS Business Overview Table 101. RAAS Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. RAAS Blood Plasma Fractionation Product Portfolio Table 103. RAAS Recent Development Table 104. CBPO Company Information Table 105. CBPO Business Overview Table 106. CBPO Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. CBPO Blood Plasma Fractionation Product Portfolio Table 108. CBPO Recent Development Table 109. Hualan Bio Company Information Table 110. Hualan Bio Business Overview Table 111. Hualan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Hualan Bio Blood Plasma Fractionation Product Portfolio Table 113. Hualan Bio Recent Development Table 114. Tiantan Bio Company Information Table 115. Tiantan Bio Business Overview Table 116. Tiantan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Tiantan Bio Blood Plasma Fractionation Product Portfolio Table 118. Tiantan Bio Recent Development Table 119. Shuanglin Bio Company Information Table 120. Shuanglin Bio Business Overview Table 121. Shuanglin Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Shuanglin Bio Blood Plasma Fractionation Product Portfolio Table 123. Shuanglin Bio Recent Development Table 124. Boya Bio Company Information Table 125. Boya Bio Business Overview Table 126. Boya Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Boya Bio Blood Plasma Fractionation Product Portfolio Table 128. Boya Bio Recent Development Table 129. Yuanda Shuyang Company Information Table 130. Yuanda Shuyang Business Overview Table 131. Yuanda Shuyang Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Yuanda Shuyang Blood Plasma Fractionation Product Portfolio Table 133. Yuanda Shuyang Recent Development Table 134. Weiguang Bio Company Information Table 135. Weiguang Bio Business Overview Table 136. Weiguang Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Weiguang Bio Blood Plasma Fractionation Product Portfolio Table 138. Weiguang Bio Recent Development Table 139. Nanyue Bio Company Information Table 140. Nanyue Bio Business Overview Table 141. Nanyue Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Nanyue Bio Blood Plasma Fractionation Product Portfolio Table 143. Nanyue Bio Recent Development Table 144. KM Biologics Company Information Table 145. KM Biologics Business Overview Table 146. KM Biologics Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. KM Biologics Blood Plasma Fractionation Product Portfolio Table 148. KM Biologics Recent Development Table 149. North America Blood Plasma Fractionation Revenue by Type (2021-2026) & (US$ Million) Table 150. North America Blood Plasma Fractionation Revenue by Type (2027-2032) & (US$ Million) Table 151. North America Blood Plasma Fractionation Sales by Type (2021-2026) & (K Units) Table 152. North America Blood Plasma Fractionation Sales by Type (2027-2032) & (K Units) Table 153. North America Blood Plasma Fractionation Sales Price by Type (2021-2026) & (US$/Unit) Table 154. North America Blood Plasma Fractionation Sales Price by Type (2027-2032) & (US$/Unit) Table 155. North America Blood Plasma Fractionation Revenue by Application (2021-2026) & (US$ Million) Table 156. North America Blood Plasma Fractionation Revenue by Application (2027-2032) & (US$ Million) Table 157. North America Blood Plasma Fractionation Sales by Application (2021-2026) & (K Units) Table 158. North America Blood Plasma Fractionation Sales by Application (2027-2032) & (K Units) Table 159. North America Blood Plasma Fractionation Sales Price by Application (2021-2026) & (US$/Unit) Table 160. North America Blood Plasma Fractionation Sales Price by Application (2027-2032) & (US$/Unit) Table 161. North America Blood Plasma Fractionation Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. North America Blood Plasma Fractionation Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. North America Blood Plasma Fractionation Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. North America Blood Plasma Fractionation Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 165. North America Blood Plasma Fractionation Sales by Country (2021-2026) & (K Units) Table 166. North America Blood Plasma Fractionation Sales by Country (2027-2032) & (K Units) Table 167. North America Blood Plasma Fractionation Sales Price by Country (2021-2026) & (US$/Unit) Table 168. North America Blood Plasma Fractionation Sales Price by Country (2027-2032) & (US$/Unit) Table 169. United States Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 170. Canada Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 171. Mexico Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 172. Europe Blood Plasma Fractionation Revenue by Type (2021-2026) & (US$ Million) Table 173. Europe Blood Plasma Fractionation Revenue by Type (2027-2032) & (US$ Million) Table 174. Europe Blood Plasma Fractionation Sales by Type (2021-2026) & (K Units) Table 175. Europe Blood Plasma Fractionation Sales by Type (2027-2032) & (K Units) Table 176. Europe Blood Plasma Fractionation Sales Price by Type (2021-2026) & (US$/Unit) Table 177. Europe Blood Plasma Fractionation Sales Price by Type (2027-2032) & (US$/Unit) Table 178. Europe Blood Plasma Fractionation Revenue by Application (2021-2026) & (US$ Million) Table 179. Europe Blood Plasma Fractionation Revenue by Application (2027-2032) & (US$ Million) Table 180. Europe Blood Plasma Fractionation Sales by Application (2021-2026) & (K Units) Table 181. Europe Blood Plasma Fractionation Sales by Application (2027-2032) & (K Units) Table 182. Europe Blood Plasma Fractionation Sales Price by Application (2021-2026) & (US$/Unit) Table 183. Europe Blood Plasma Fractionation Sales Price by Application (2027-2032) & (US$/Unit) Table 184. Europe Blood Plasma Fractionation Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Europe Blood Plasma Fractionation Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Europe Blood Plasma Fractionation Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Europe Blood Plasma Fractionation Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. Europe Blood Plasma Fractionation Sales by Country (2021-2026) & (K Units) Table 189. Europe Blood Plasma Fractionation Sales by Country (2027-2032) & (K Units) Table 190. Europe Blood Plasma Fractionation Sales Price by Country (2021-2026) & (US$/Unit) Table 191. Europe Blood Plasma Fractionation Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Germany Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 193. France Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 194. U.K. Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 195. Italy Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 196. Russia Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 197. Spain Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 198. Netherlands Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 199. Switzerland Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 200. Sweden Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 201. Poland Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 202. China Blood Plasma Fractionation Revenue by Type (2021-2026) & (US$ Million) Table 203. China Blood Plasma Fractionation Revenue by Type (2027-2032) & (US$ Million) Table 204. China Blood Plasma Fractionation Sales by Type (2021-2026) & (K Units) Table 205. China Blood Plasma Fractionation Sales by Type (2027-2032) & (K Units) Table 206. China Blood Plasma Fractionation Sales Price by Type (2021-2026) & (US$/Unit) Table 207. China Blood Plasma Fractionation Sales Price by Type (2027-2032) & (US$/Unit) Table 208. China Blood Plasma Fractionation Revenue by Application (2021-2026) & (US$ Million) Table 209. China Blood Plasma Fractionation Revenue by Application (2027-2032) & (US$ Million) Table 210. China Blood Plasma Fractionation Sales by Application (2021-2026) & (K Units) Table 211. China Blood Plasma Fractionation Sales by Application (2027-2032) & (K Units) Table 212. China Blood Plasma Fractionation Sales Price by Application (2021-2026) & (US$/Unit) Table 213. China Blood Plasma Fractionation Sales Price by Application (2027-2032) & (US$/Unit) Table 214. Asia Blood Plasma Fractionation Revenue by Type (2021-2026) & (US$ Million) Table 215. Asia Blood Plasma Fractionation Revenue by Type (2027-2032) & (US$ Million) Table 216. Asia Blood Plasma Fractionation Sales by Type (2021-2026) & (K Units) Table 217. Asia Blood Plasma Fractionation Sales by Type (2027-2032) & (K Units) Table 218. Asia Blood Plasma Fractionation Sales Price by Type (2021-2026) & (US$/Unit) Table 219. Asia Blood Plasma Fractionation Sales Price by Type (2027-2032) & (US$/Unit) Table 220. Asia Blood Plasma Fractionation Revenue by Application (2021-2026) & (US$ Million) Table 221. Asia Blood Plasma Fractionation Revenue by Application (2027-2032) & (US$ Million) Table 222. Asia Blood Plasma Fractionation Sales by Application (2021-2026) & (K Units) Table 223. Asia Blood Plasma Fractionation Sales by Application (2027-2032) & (K Units) Table 224. Asia Blood Plasma Fractionation Sales Price by Application (2021-2026) & (US$/Unit) Table 225. Asia Blood Plasma Fractionation Sales Price by Application (2027-2032) & (US$/Unit) Table 226. Asia Blood Plasma Fractionation Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. Asia Blood Plasma Fractionation Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. Asia Blood Plasma Fractionation Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. Asia Blood Plasma Fractionation Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 230. Asia Blood Plasma Fractionation Sales by Country (2021-2026) & (K Units) Table 231. Asia Blood Plasma Fractionation Sales by Country (2027-2032) & (K Units) Table 232. Asia Blood Plasma Fractionation Sales Price by Country (2021-2026) & (US$/Unit) Table 233. Asia Blood Plasma Fractionation Sales Price by Country (2027-2032) & (US$/Unit) Table 234. Japan Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 235. South Korea Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 236. India Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 237. Australia Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 238. Taiwan Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 239. Southeast Asia Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 240. SAMEA Blood Plasma Fractionation Revenue by Type (2021-2026) & (US$ Million) Table 241. SAMEA Blood Plasma Fractionation Revenue by Type (2027-2032) & (US$ Million) Table 242. SAMEA Blood Plasma Fractionation Sales by Type (2021-2026) & (K Units) Table 243. SAMEA Blood Plasma Fractionation Sales by Type (2027-2032) & (K Units) Table 244. SAMEA Blood Plasma Fractionation Sales Price by Type (2021-2026) & (US$/Unit) Table 245. SAMEA Blood Plasma Fractionation Sales Price by Type (2027-2032) & (US$/Unit) Table 246. SAMEA Blood Plasma Fractionation Revenue by Application (2021-2026) & (US$ Million) Table 247. SAMEA Blood Plasma Fractionation Revenue by Application (2027-2032) & (US$ Million) Table 248. SAMEA Blood Plasma Fractionation Sales by Application (2021-2026) & (K Units) Table 249. SAMEA Blood Plasma Fractionation Sales by Application (2027-2032) & (K Units) Table 250. SAMEA Blood Plasma Fractionation Sales Price by Application (2021-2026) & (US$/Unit) Table 251. SAMEA Blood Plasma Fractionation Sales Price by Application (2027-2032) & (US$/Unit) Table 252. SAMEA Blood Plasma Fractionation Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 253. SAMEA Blood Plasma Fractionation Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 254. SAMEA Blood Plasma Fractionation Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 255. SAMEA Blood Plasma Fractionation Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 256. SAMEA Blood Plasma Fractionation Sales by Country (2021-2026) & (K Units) Table 257. SAMEA Blood Plasma Fractionation Sales by Country (2027-2032) & (K Units) Table 258. SAMEA Blood Plasma Fractionation Sales Price by Country (2021-2026) & (US$/Unit) Table 259. SAMEA Blood Plasma Fractionation Sales Price by Country (2027-2032) & (US$/Unit) Table 260. Brazil Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 261. Argentina Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 262. Chile Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 263. Colombia Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 264. Peru Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 265. Saudi Arabia Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 266. Israel Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 267. UAE Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 268. Turkey Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 269. Iran Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 270. Egypt Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Table 271. Key Raw Materials Table 272. Raw Materials Key Suppliers Table 273. Blood Plasma Fractionation Distributors List Table 274. Blood Plasma Fractionation Customers List Table 275. Research Programs/Design for This Report Table 276. Authors List of This Report Table 277. Secondary Sources Table 278. Primary Sources List of Figures Figure 1. Blood Plasma Fractionation Image Figure 2. Global Blood Plasma Fractionation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Plasma Fractionation Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immune Globulin Image Figure 5. Coagulation Factor Image Figure 6. Albumin Image Figure 7. Others Image Figure 8. Global Blood Plasma Fractionation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Blood Plasma Fractionation Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Retail Pharmacy Image Figure 12. Others Image Figure 13. Global Blood Plasma Fractionation Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Blood Plasma Fractionation Revenue (2021-2032) & (US$ Million) Figure 15. Global Blood Plasma Fractionation Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Blood Plasma Fractionation Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Blood Plasma Fractionation Revenue Market Share by Region (2021-2032) Figure 18. Global Blood Plasma Fractionation Sales (2021-2032) & (K Units) Figure 19. Global Blood Plasma Fractionation Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Blood Plasma Fractionation Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Blood Plasma Fractionation Sales YoY (2021-2032) & (K Units) Figure 22. Europe Blood Plasma Fractionation Sales YoY (2021-2032) & (K Units) Figure 23. China Blood Plasma Fractionation Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Blood Plasma Fractionation Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Blood Plasma Fractionation Sales YoY (2021-2032) & (K Units) Figure 26. Global Blood Plasma Fractionation Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Blood Plasma Fractionation Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Blood Plasma Fractionation Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Blood Plasma Fractionation Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Blood Plasma Fractionation Revenue Market Share by Type (2021-2032) Figure 32. Global Blood Plasma Fractionation Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Blood Plasma Fractionation Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Blood Plasma Fractionation Sales Market Share by Type (2021-2032) Figure 35. Global Blood Plasma Fractionation Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Blood Plasma Fractionation Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Blood Plasma Fractionation Revenue Market Share by Application (2021-2032) Figure 38. Global Blood Plasma Fractionation Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Blood Plasma Fractionation Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Blood Plasma Fractionation Sales Market Share by Application (2021-2032) Figure 41. North America Blood Plasma Fractionation Revenue Share by Type (2021-2032) Figure 42. North America Blood Plasma Fractionation Sales Share by Type (2021-2032) Figure 43. North America Blood Plasma Fractionation Revenue Share by Application (2021-2032) Figure 44. North America Blood Plasma Fractionation Sales Share by Application (2021-2032) Figure 45. North America Blood Plasma Fractionation Revenue Share by Country (2021-2032) Figure 46. North America Blood Plasma Fractionation Sales Share by Country (2021-2032) Figure 47. Europe Blood Plasma Fractionation Revenue Share by Type (2021-2032) Figure 48. Europe Blood Plasma Fractionation Sales Share by Type (2021-2032) Figure 49. Europe Blood Plasma Fractionation Revenue Share by Application (2021-2032) Figure 50. Europe Blood Plasma Fractionation Sales Share by Application (2021-2032) Figure 51. Europe Blood Plasma Fractionation Revenue Share by Country (2021-2032) Figure 52. Europe Blood Plasma Fractionation Sales Share by Country (2021-2032) Figure 53. China Blood Plasma Fractionation Revenue Share by Type (2021-2032) Figure 54. China Blood Plasma Fractionation Sales Share by Type (2021-2032) Figure 55. China Blood Plasma Fractionation Revenue Share by Application (2021-2032) Figure 56. China Blood Plasma Fractionation Sales Share by Application (2021-2032) Figure 57. Asia Blood Plasma Fractionation Revenue Share by Type (2021-2032) Figure 58. Asia Blood Plasma Fractionation Sales Share by Type (2021-2032) Figure 59. Asia Blood Plasma Fractionation Revenue Share by Application (2021-2032) Figure 60. Asia Blood Plasma Fractionation Sales Share by Application (2021-2032) Figure 61. Asia Blood Plasma Fractionation Revenue Share by Country (2021-2032) Figure 62. Asia Blood Plasma Fractionation Sales Share by Country (2021-2032) Figure 63. SAMEA Blood Plasma Fractionation Revenue Share by Type (2021-2032) Figure 64. SAMEA Blood Plasma Fractionation Sales Share by Type (2021-2032) Figure 65. SAMEA Blood Plasma Fractionation Revenue Share by Application (2021-2032) Figure 66. SAMEA Blood Plasma Fractionation Sales Share by Application (2021-2032) Figure 67. SAMEA Blood Plasma Fractionation Revenue Share by Country (2021-2032) Figure 68. SAMEA Blood Plasma Fractionation Sales Share by Country (2021-2032) Figure 69. Blood Plasma Fractionation Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Blood Plasma Fractionation Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Immune Globulin
  • Coagulation Factor
  • Albumin
  • Others
Applications
  • Hospital
  • Retail Pharmacy
  • Others
Companies covered
  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Boya Bio
  • Yuanda Shuyang
  • Weiguang Bio
  • Nanyue Bio
  • KM Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Blood Plasma Fractionation Market by Type
  3. 1.2.1 Global Blood Plasma Fractionation Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immune Globulin
  5. 1.2.3 Coagulation Factor
  6. 1.2.4 Albumin
  7. 1.2.5 Others
  8. 1.3 Blood Plasma Fractionation Market by Application
  9. 1.3.1 Global Blood Plasma Fractionation Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Retail Pharmacy
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Blood Plasma Fractionation Market Dynamics
  1. 2.1 Blood Plasma Fractionation Industry Trends
  2. 2.2 Blood Plasma Fractionation Industry Drivers
  3. 2.3 Blood Plasma Fractionation Industry Opportunities and Challenges
  4. 2.4 Blood Plasma Fractionation Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Blood Plasma Fractionation Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Blood Plasma Fractionation Revenue by Region
  3. 3.2.1 Global Blood Plasma Fractionation Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Blood Plasma Fractionation Revenue by Region (2021-2026)
  5. 3.2.3 Global Blood Plasma Fractionation Revenue by Region (2027-2032)
  6. 3.2.4 Global Blood Plasma Fractionation Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Blood Plasma Fractionation Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Blood Plasma Fractionation Sales by Region
  9. 3.4.1 Global Blood Plasma Fractionation Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Blood Plasma Fractionation Sales by Region (2021-2026)
  11. 3.4.3 Global Blood Plasma Fractionation Sales by Region (2027-2032)
  12. 3.4.4 Global Blood Plasma Fractionation Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Blood Plasma Fractionation Revenue by Manufacturers
  2. 4.1.1 Global Blood Plasma Fractionation Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Blood Plasma Fractionation Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Blood Plasma Fractionation Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Blood Plasma Fractionation Sales by Manufacturers
  6. 4.2.1 Global Blood Plasma Fractionation Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Blood Plasma Fractionation Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Blood Plasma Fractionation Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Blood Plasma Fractionation Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Blood Plasma Fractionation Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Blood Plasma Fractionation Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Blood Plasma Fractionation Manufacturers, Product Type & Application
  13. 4.7 Global Blood Plasma Fractionation Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Blood Plasma Fractionation Market CR5 and HHI
  16. 4.8.2 2025 Blood Plasma Fractionation Tier 1, Tier 2, and Tier 3
5 Blood Plasma Fractionation Market by Type
  1. 5.1 Global Blood Plasma Fractionation Revenue by Type
  2. 5.1.1 Global Blood Plasma Fractionation Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Blood Plasma Fractionation Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Blood Plasma Fractionation Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Blood Plasma Fractionation Sales by Type
  6. 5.2.1 Global Blood Plasma Fractionation Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blood Plasma Fractionation Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Blood Plasma Fractionation Sales Market Share by Type (2021-2032)
  9. 5.3 Global Blood Plasma Fractionation Price by Type
6 Blood Plasma Fractionation Market by Application
  1. 6.1 Global Blood Plasma Fractionation Revenue by Application
  2. 6.1.1 Global Blood Plasma Fractionation Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Blood Plasma Fractionation Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Blood Plasma Fractionation Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Blood Plasma Fractionation Sales by Application
  6. 6.2.1 Global Blood Plasma Fractionation Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Blood Plasma Fractionation Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Blood Plasma Fractionation Sales Market Share by Application (2021-2032)
  9. 6.3 Global Blood Plasma Fractionation Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Blood Plasma Fractionation Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 CSL
  8. 7.2.1 CSL Company Information
  9. 7.2.2 CSL Business Overview
  10. 7.2.3 CSL Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CSL Blood Plasma Fractionation Product Portfolio
  12. 7.2.5 CSL Recent Developments
  13. 7.3 Grifols
  14. 7.3.1 Grifols Company Information
  15. 7.3.2 Grifols Business Overview
  16. 7.3.3 Grifols Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Grifols Blood Plasma Fractionation Product Portfolio
  18. 7.3.5 Grifols Recent Developments
  19. 7.4 Octapharma
  20. 7.4.1 Octapharma Company Information
  21. 7.4.2 Octapharma Business Overview
  22. 7.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Octapharma Blood Plasma Fractionation Product Portfolio
  24. 7.4.5 Octapharma Recent Developments
  25. 7.5 Kedrion
  26. 7.5.1 Kedrion Company Information
  27. 7.5.2 Kedrion Business Overview
  28. 7.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Kedrion Blood Plasma Fractionation Product Portfolio
  30. 7.5.5 Kedrion Recent Developments
  31. 7.6 LFB Group
  32. 7.6.1 LFB Group Company Information
  33. 7.6.2 LFB Group Business Overview
  34. 7.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 LFB Group Blood Plasma Fractionation Product Portfolio
  36. 7.6.5 LFB Group Recent Developments
  37. 7.7 Biotest
  38. 7.7.1 Biotest Company Information
  39. 7.7.2 Biotest Business Overview
  40. 7.7.3 Biotest Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Biotest Blood Plasma Fractionation Product Portfolio
  42. 7.7.5 Biotest Recent Developments
  43. 7.8 BPL
  44. 7.8.1 BPL Company Information
  45. 7.8.2 BPL Business Overview
  46. 7.8.3 BPL Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 BPL Blood Plasma Fractionation Product Portfolio
  48. 7.8.5 BPL Recent Developments
  49. 7.9 RAAS
  50. 7.9.1 RAAS Company Information
  51. 7.9.2 RAAS Business Overview
  52. 7.9.3 RAAS Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 RAAS Blood Plasma Fractionation Product Portfolio
  54. 7.9.5 RAAS Recent Developments
  55. 7.10 CBPO
  56. 7.10.1 CBPO Company Information
  57. 7.10.2 CBPO Business Overview
  58. 7.10.3 CBPO Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 CBPO Blood Plasma Fractionation Product Portfolio
  60. 7.10.5 CBPO Recent Developments
  61. 7.11 Hualan Bio
  62. 7.11.1 Hualan Bio Company Information
  63. 7.11.2 Hualan Bio Business Overview
  64. 7.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hualan Bio Blood Plasma Fractionation Product Portfolio
  66. 7.11.5 Hualan Bio Recent Developments
  67. 7.12 Tiantan Bio
  68. 7.12.1 Tiantan Bio Company Information
  69. 7.12.2 Tiantan Bio Business Overview
  70. 7.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Tiantan Bio Blood Plasma Fractionation Product Portfolio
  72. 7.12.5 Tiantan Bio Recent Developments
  73. 7.13 Shuanglin Bio
  74. 7.13.1 Shuanglin Bio Company Information
  75. 7.13.2 Shuanglin Bio Business Overview
  76. 7.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Shuanglin Bio Blood Plasma Fractionation Product Portfolio
  78. 7.13.5 Shuanglin Bio Recent Developments
  79. 7.14 Boya Bio
  80. 7.14.1 Boya Bio Company Information
  81. 7.14.2 Boya Bio Business Overview
  82. 7.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Boya Bio Blood Plasma Fractionation Product Portfolio
  84. 7.14.5 Boya Bio Recent Developments
  85. 7.15 Yuanda Shuyang
  86. 7.15.1 Yuanda Shuyang Company Information
  87. 7.15.2 Yuanda Shuyang Business Overview
  88. 7.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Yuanda Shuyang Blood Plasma Fractionation Product Portfolio
  90. 7.15.5 Yuanda Shuyang Recent Developments
  91. 7.16 Weiguang Bio
  92. 7.16.1 Weiguang Bio Company Information
  93. 7.16.2 Weiguang Bio Business Overview
  94. 7.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Weiguang Bio Blood Plasma Fractionation Product Portfolio
  96. 7.16.5 Weiguang Bio Recent Developments
  97. 7.17 Nanyue Bio
  98. 7.17.1 Nanyue Bio Company Information
  99. 7.17.2 Nanyue Bio Business Overview
  100. 7.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Nanyue Bio Blood Plasma Fractionation Product Portfolio
  102. 7.17.5 Nanyue Bio Recent Developments
  103. 7.18 KM Biologics
  104. 7.18.1 KM Biologics Company Information
  105. 7.18.2 KM Biologics Business Overview
  106. 7.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 KM Biologics Blood Plasma Fractionation Product Portfolio
  108. 7.18.5 KM Biologics Recent Developments
8 North America
  1. 8.1 North America Blood Plasma Fractionation Market Size by Type
  2. 8.1.1 North America Blood Plasma Fractionation Revenue by Type (2021-2032)
  3. 8.1.2 North America Blood Plasma Fractionation Sales by Type (2021-2032)
  4. 8.1.3 North America Blood Plasma Fractionation Price by Type (2021-2032)
  5. 8.2 North America Blood Plasma Fractionation Market Size by Application
  6. 8.2.1 North America Blood Plasma Fractionation Revenue by Application (2021-2032)
  7. 8.2.2 North America Blood Plasma Fractionation Sales by Application (2021-2032)
  8. 8.2.3 North America Blood Plasma Fractionation Price by Application (2021-2032)
  9. 8.3 North America Blood Plasma Fractionation Market Size by Country
  10. 8.3.1 North America Blood Plasma Fractionation Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Blood Plasma Fractionation Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Blood Plasma Fractionation Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Blood Plasma Fractionation Market Size by Type
  2. 9.1.1 Europe Blood Plasma Fractionation Revenue by Type (2021-2032)
  3. 9.1.2 Europe Blood Plasma Fractionation Sales by Type (2021-2032)
  4. 9.1.3 Europe Blood Plasma Fractionation Price by Type (2021-2032)
  5. 9.2 Europe Blood Plasma Fractionation Market Size by Application
  6. 9.2.1 Europe Blood Plasma Fractionation Revenue by Application (2021-2032)
  7. 9.2.2 Europe Blood Plasma Fractionation Sales by Application (2021-2032)
  8. 9.2.3 Europe Blood Plasma Fractionation Price by Application (2021-2032)
  9. 9.3 Europe Blood Plasma Fractionation Market Size by Country
  10. 9.3.1 Europe Blood Plasma Fractionation Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Blood Plasma Fractionation Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Blood Plasma Fractionation Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Blood Plasma Fractionation Market Size by Type
  2. 10.1.1 China Blood Plasma Fractionation Revenue by Type (2021-2032)
  3. 10.1.2 China Blood Plasma Fractionation Sales by Type (2021-2032)
  4. 10.1.3 China Blood Plasma Fractionation Price by Type (2021-2032)
  5. 10.2 China Blood Plasma Fractionation Market Size by Application
  6. 10.2.1 China Blood Plasma Fractionation Revenue by Application (2021-2032)
  7. 10.2.2 China Blood Plasma Fractionation Sales by Application (2021-2032)
  8. 10.2.3 China Blood Plasma Fractionation Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Blood Plasma Fractionation Market Size by Type
  2. 11.1.1 Asia Blood Plasma Fractionation Revenue by Type (2021-2032)
  3. 11.1.2 Asia Blood Plasma Fractionation Sales by Type (2021-2032)
  4. 11.1.3 Asia Blood Plasma Fractionation Price by Type (2021-2032)
  5. 11.2 Asia Blood Plasma Fractionation Market Size by Application
  6. 11.2.1 Asia Blood Plasma Fractionation Revenue by Application (2021-2032)
  7. 11.2.2 Asia Blood Plasma Fractionation Sales by Application (2021-2032)
  8. 11.2.3 Asia Blood Plasma Fractionation Price by Application (2021-2032)
  9. 11.3 Asia Blood Plasma Fractionation Market Size by Country
  10. 11.3.1 Asia Blood Plasma Fractionation Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Blood Plasma Fractionation Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Blood Plasma Fractionation Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Blood Plasma Fractionation Market Size by Type
  2. 12.1.1 SAMEA Blood Plasma Fractionation Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Blood Plasma Fractionation Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Blood Plasma Fractionation Price by Type (2021-2032)
  5. 12.2 SAMEA Blood Plasma Fractionation Market Size by Application
  6. 12.2.1 SAMEA Blood Plasma Fractionation Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Blood Plasma Fractionation Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Blood Plasma Fractionation Price by Application (2021-2032)
  9. 12.3 SAMEA Blood Plasma Fractionation Market Size by Country
  10. 12.3.1 SAMEA Blood Plasma Fractionation Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Blood Plasma Fractionation Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Blood Plasma Fractionation Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Blood Plasma Fractionation Value Chain Analysis
  2. 13.1.1 Blood Plasma Fractionation Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Blood Plasma Fractionation Production Mode & Process
  6. 13.2 Blood Plasma Fractionation Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Blood Plasma Fractionation Distributors
  9. 13.2.3 Blood Plasma Fractionation Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst